These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2478285)

  • 1. Effects of arotinolol on serum lipid and apolipoprotein levels in patients with mild essential hypertension.
    Sasaki J; Handa K; Arakawa K
    Clin Ther; 1989; 11(5):580-3. PubMed ID: 2478285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
    Sasaki J; Kajiyama G; Kusukawa R; Mori H; Koga S; Takagi R; Tanaka N; Ogawa N; Arakawa K
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):660-4. PubMed ID: 7881705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pinacidil on serum lipid, lipoprotein, and apolipoprotein levels in patients with mild to moderate hypertension.
    Saku K; Ying H; Arakawa K
    Clin Ther; 1990; 12(2):132-8. PubMed ID: 2354482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid profile improvement following celiprolol.
    Herrmann JM; von Heyman F; Freischütz G
    J Int Med Res; 1988; 16 Suppl 1():39A-46A. PubMed ID: 2906016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
    Sourgens H; Schmidt J; Derendorf H
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of captopril on high-density lipoprotein subfractions in patients with mild to moderate essential hypertension.
    Sasaki J; Arakawa K
    Clin Ther; 1989; 11(1):129-34. PubMed ID: 2655902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of manidipine and delapril on serum lipids, lipoproteins, and apolipoproteins in patients with mild to moderate essential hypertension: a randomized trial with one-year follow-up.
    Saku K; Zhang B; Hirata K; Liu R; Sasaki N; Sakai T; Ying H; Arakawa K
    Clin Ther; 1992; 14(6):813-20. PubMed ID: 1286488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipid levels in hypertensive patients during captopril treatment.
    Nishide T; Shirai K; Shinomiya M; Ishikawa Y; Murano S; Morisaki N; Saito Y; Yoshida S; Sasaki N
    Clin Ther; 1989; 11(6):820-7. PubMed ID: 2692824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of bunazosin and propranolol on serum lipids and apolipoproteins in patients with essential hypertension.
    Sasaki J; Koga S; Uzawa H; Arakawa K
    Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):402-7. PubMed ID: 2676872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pindolol on serum lipids, apolipoproteins, and lipoproteins in patients with mild to moderate essential hypertension.
    Sasaki J; Saku K; Ideishi M; Arakawa K; Kato Y; Kuwano E; So T
    Clin Ther; 1989; 11(2):219-24. PubMed ID: 2736568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a new alpha 1-blocker, bunazosin hydrochloride, on plasma lipid components in hypertensive patients with hypercholesterolemia.
    Yashiro A; Sugano M; Nakashima Y; Tasaki H; Kuroiwa A
    Clin Ther; 1987; 10(1):98-106. PubMed ID: 2897239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of enalapril on serum lipoproteins in mild essential hypertension.
    Sasaki J; Arakawa K
    Clin Ther; 1989; 11(1):38-42. PubMed ID: 2541908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do beta-blockers alter lipids and what are the consequences?
    Holtzman E; Rosenthal T; Goldbourt U; Segal P
    J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S86-92; discussion S93. PubMed ID: 2481177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medium-term effects of betaxolol monotherapy and combination therapy with nitrendipine on lipoprotein and apolipoprotein metabolism in patients with mild to moderate essential hypertension.
    Saku K; Zhang B; Okamoto T; Takeda Y; Liu K; Jimi S; Arakawa K
    J Hum Hypertens; 1996 Apr; 10(4):263-8. PubMed ID: 8736459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect on HDL cholesterol of oxprenolol and atenolol.
    Kjeldsen SE; Eide I; Leren P; Foss OP; Holme I; Eriksen IL
    Scand J Clin Lab Invest; 1982 Sep; 42(5):449-53. PubMed ID: 6130595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open assessment of the effect of prazosin on plasma lipids.
    Havard CW; Khokhar AM; Flax JS
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S238-41. PubMed ID: 6177964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(3):331-40. PubMed ID: 2743372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fosinopril on the blood pressure and lipid profile of patients undergoing heart transplantation.
    Almenar L; Osa A; Palencia M; Flores A; Sánchez E
    J Heart Lung Transplant; 1997 Apr; 16(4):454-9. PubMed ID: 9154957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of carvedilol on serum lipids in patients with essential hypertension.
    Goto Y; Tamachi H; Fusegawa Y; Nakaya N; Homma Y; Mikami M; Iori S; Yamazaki A
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S45-50. PubMed ID: 1721979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.